Histofy and Source BioScience UK Announce Strategic Partnership to Advance AI-Powered Pathology in the UK

Histofy, a leading UK based pathology AI company focused on accelerating histopathology workflows in both clinical and pharmaceutical sectors, is proud to announce a strategic partnership with Source BioScience UK Limited, the largest histopathology service provider in the United Kingdom. This collaboration aims to accelerate the deployment of AI-driven diagnostics, improving accuracy, efficiency, and scalability of histopathological workflows.

Through this strategic investment by Source BioScience into Histofy, the two companies will explore AI-based workflow efficiencies and integration of Histofy’s cutting-edge AI technology into Source BioScience’s state-of-the-art pathology laboratories. The initiative will firstly focus on enhancing laboratory workflows and accelerating diagnostic services, with a view to scaling AI-powered diagnostics across Source BioScience’s full range of laboratory services.

Professor Nasir Rajpoot, CEO & CSO of Histofy, commented:

“This is a major milestone for Histofy. Partnering with Source BioScience will enable our AI solutions to have a direct impact on patient care at scale, across one of the most trusted laboratory networks in the UK. Together, we are laying the foundation for the next generation of AI-enabled digital pathology services — ones that combine deep clinical expertise with cutting-edge artificial intelligence.”

Jay LeCoque, CEO and Executive Chairman of Source BioScience, added:

“Partnering with Histofy will allow us to accelerate our AI capabilities and improve our service offering to the NHS and private healthcare providers. Our combined goal is to improve patient care by providing much needed solutions for pathologists to fully engage AI as a widely accepted cancer detection and diagnostic tool.”

The partnership will also help improve operational efficiencies and create new business opportunities through AI-enabled services and clinical trial support. It also opens the door for R&D collaborations and co-development of new AI-enabled pathology assays.

About Histofy
Histofy is a UK-based pathology AI spinout from the University of Warwick that builds data-efficient transparent AI tools for histopathology. Its mission is to empower pathologists and healthcare providers with innovative software that accelerates pathologist decision-making and improves patient outcomes.

About Source BioScience
Source BioScience is an international provider of the state-of-the-art laboratory services, including digital pathology, diagnostics, clinical research services and genomics. With an expanding footprint of UKAS-accredited laboratories and a long-standing reputation for quality, Source BioScience supports both the NHS and private sector with quality-led laboratory services.

For media inquiries, please contact Nasir Rajpoot at n.rajpoot@histofy.ai or Klaudyna Johnstone at klaudyna.johnstone@sourcebioscience.com

For more information on Histofy, visit: https://histofy.ai/

For more information about Source BioScience, visit: https://sourcebioscience.com/